Henan: Users with large electricity consumption are encouraged to configure efficient and flexible energy storage systems to realize peak load shedding and valley filling. The General Office of the People's Government of Henan Province issued a notice on the implementation plan of accelerating the integration of source, grid, load and storage in Henan Province, which proposed to actively develop diversified energy storage routes. Encourage the incremental distribution network to build long-term energy storage facilities to alleviate the long-term balance adjustment pressure caused by the mismatch between new energy generation characteristics and load characteristics. Encourage users with large electricity consumption to configure efficient and flexible energy storage systems, realize peak shaving and valley filling, and promote the time-space matching of power generation and electricity consumption. In areas with high reliability requirements for power supply such as transportation and communication, we will encourage the construction of new mobile or fixed energy storage facilities to improve emergency power supply support capabilities.SpaceX is valued at about $350 billion due to internal stock sales. According to an email sent to employees seen by the media, SpaceX and its investors have agreed to acquire the company's common stock of up to $1.25 billion at a price of $185 per share. This transaction values the rocket and satellite manufacturer owned by elon musk at about $350 billion. The memo said that the price of $185 per share was much higher than the valuation of $112 less than three months ago. The memorandum was further confirmed by insiders. According to the memo, only SpaceX offered to buy up to $500 million in common stock.Iran's Supreme Leader Ayatollah Ali Khamenei: Syria's occupied areas will be liberated.
Senior US official: Russia has provided important assistance to Iran in fighter planes, missile defense and space technology.SpaceX is valued at about $350 billion due to internal stock sales. According to an email sent to employees seen by the media, SpaceX and its investors have agreed to acquire the company's common stock of up to $1.25 billion at a price of $185 per share. This transaction values the rocket and satellite manufacturer owned by elon musk at about $350 billion.Trump said that individuals or companies that invest more than $1 billion in the United States will get accelerated approval. US President-elect Trump wrote in a post on his social media Truth Social on Tuesday: "Any individual or company that invests more than $1 billion in the United States will get comprehensive and accelerated approval and permission, including but not limited to all environmental approvals." This is the latest sign that Trump intends to relax the supervision of federal agencies and attract more foreign investment during his second term.
Huadian energy: The subordinate power plants and holding companies received government subsidies of 22.33 million yuan. huadian energy announced that the subordinate power plants and holding companies of the company received government subsidies related to income of 22.33 million yuan on December 9, 2024. Among them, Harbin No.3 Power Plant of huadian energy Co., Ltd. received a government subsidy of 10.87 million yuan, and Harbin Thermal Power Co., Ltd. received a government subsidy of 11.46 million yuan. In accordance with the relevant provisions of Accounting Standards for Business Enterprises No.16-Government Subsidies, the company included this subsidy in the current profit and loss, and it is estimated that the total profit of the company in 2024 will be increased by 8.39 million yuan.Sichuan issued 30-year ordinary special local bonds, with a scale of 35.4 billion yuan, an issue interest rate of 2.2000%, a marginal multiple of 1.58 times and an expected multiple of 2.19.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.
Strategy guide
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
Strategy guide
12-14